Now: Previous uninsured cost: $1,349 per month ($16,188 annually) New cash-pay cost: $349 per month ($4,188 annually with intro pricing) Reduction: $12,000 annual savings versus previous pricing This makes brand-name GLP-1 medications accessible to a much broader population than before
Retatrutide targets three (GLP-1, GIP, and Glucagon), which researchers believe may lead to more significant metabolic improvements
Effect of weight loss on blood pressure changes in overweight patients: A systematic review and meta-analysis
What This Means for Patients People living with obesity alongside type 2 diabetes or established cardiovascular disease often face greater challenges achieving meaningful and sustained weight loss while managing the health risks associated with these conditions
No one yet, but there are some formidable players
However, the lawsuit currently presents allegations, and the court has not ruled that Lillys advertising violated the law